Table 2.
The distribution of anthropometric variables in patients with low SYNTAX score (< 21)
| Variables | Total | Syntax Score < 21; n(%) | ||||
|---|---|---|---|---|---|---|
| 0 | 0.01–9 | 9.1–21 | P-value | |||
| Gender (frequency, percentile) | Male | 513 | 200(39.0%) | 175(34.1%) | 138(26.9%) | < 0.001 |
| Female | 354 | 194(54.8%) | 102(28.8%) | 58(16.4%) | ||
| Age groups (years) | < 40 | 51 | 35(68.6%) | 11(21.6%) | 5(9.8%) | < 0.001 |
| 40–49 | 164 | 102(62.2%) | 39(23.8%) | 23(14.0%) | ||
| 50–59 | 328 | 139(42.4%) | 114(34.8%) | 75(22.9%) | ||
| 60–69 | 217 | 88(40.6%) | 70(32.3%) | 59(27.2%) | ||
| > = 70 | 107 | 30(28.0%) | 43(40.2%) | 34(31.8%) | ||
| HTN frequency, percentile) | Yes | 536 | 219(40.9%) | 183(34.1%) | 134(25.0%) | 0.002 |
| No | 331 | 175(52.9%) | 94(28.4%) | 62(18.7%) | ||
| DM (frequency, percentile) | Yes-Insulin | 86 | 31(36.0%) | 27(31.4%) | 28(32.6%) | 0.031 |
| -noninsulin | 234 | 98(41.9%) | 75(32.1%) | 61(26.1%) | ||
| no | 547 | 265(48.4%) | 175(32.0%) | 107(19.6%) | ||
| DM (frequency, percentile) | Yes | 320 | 129(40.3%) | 102(31.9%) | 89(27.8%) | 0.011 |
| No | 547 | 265(48.4%) | 175(32.0%) | 107(19.6%) | ||
| CABG or PCI frequency, percentile) | Yes | 100 | 36(36.0%) | 45(45.0%) | 19(19.0%) | 0.011 |
| No | 755 | 353(46.8%) | 228(30.2%) | 174(23.0%) | ||
| ACS or HF frequency, percentile) | Yes | 366 | 134(36.6%) | 143(39.1%) | 89(24.3%) | < 0.001 |
| No | 501 | 260(51.9%) | 134(26.7%) | 107(21.4%) | ||
| FH of premature CAD frequency, percentile) | Yes | 502 | 240(47.8%) | 159(31.7%) | 103(20.5%) | 0.150 |
| No | 365 | 154(42.2%) | 118(32.3%) | 93(25.5%) | ||
| Smoker frequency, percentile) | Yes | 138 | 49(35.5%) | 48(34.8%) | 41(29.7%) | 0.021 |
| No | 728 | 345(47.4%) | 229(31.5%) | 154(21.2%) | ||
| Menopause frequency, percentile) | Yes | 247 | 120(48.6%) | 79(32.0%) | 48(19.4%) | 0.001 |
| No | 107 | 74(69.2%) | 23(21.5%) | 10(9.3%) | ||
| HRT frequency, percentile) | Yes | 71 | 44(62.0%) | 18(25.4%) | 9(12.7%) | 0.011 |
| No | 796 | 350(44.0%) | 259(32.5%) | 187(23.5%) | ||
| MI (frequency, percentile) | Yes | 53 | 9(17.0%) | 28(52.8%) | 16(30.2%) | < 0.001 |
| No | 814 | 385(47.3%) | 249(30.6%) | 180(22.1%) | ||
| ACS (frequency, percentile) | Yes | 330 | 122(37.0%) | 126(38.2%) | 82(24.8%) | < 0.001 |
| No | 537 | 272(50.7%) | 151(28.1%) | 114(21.2%) | ||
| Type of presentation (frequency, percentile) | STEMI | 61 | 9(14.8%) | 32(52.5%) | 20(32.8%) | < 0.001 |
| NSTEMI | 36 | 6(16.7%) | 16(44.4%) | 14(38.9%) | ||
| Unstable Angina | 25 | 8(32.0%) | 8(32.0%) | 9(36.0%) | ||
| Stable Angina | 622 | 297(47.7%) | 192(30.9%) | 133(21.4%) | ||
| Others | 123 | 74(60.2%) | 29(23.6%) | 20(16.3%) | ||
| WC (cm) | < 102 or < 88 | 311 | 114(36.7%) | 113(36.3%) | 84(27.0%) | < 0.001 |
| > = 102 or > =88 | 556 | 280(50.4%) | 164(29.5%) | 112(20.1%) | ||
| W/HR | <=0.9 or < =0.85 | 26 | 14(53.8%) | 5(19.2%) | 7(26.9%) | 0.369 |
| > 0.9 or > 0.85 | 841 | 380(45.2%) | 272(32.3%) | 189(22.5%) | ||
| W/HtR | < 0.5 | 51 | 19(37.3%) | 17(33.3%) | 15(29.4%) | 0.379 |
| > = 0.5 | 816 | 375(46.0%) | 260(31.9%) | 181(22.2%) | ||
| BMI (kg/m2) | < 25 | 191 | 70(36.6%) | 67(35.1%) | 54(28.3%) | 0.004 |
| 25–29 | 392 | 173(44.1%) | 125(31.9%) | 94(24.0%) | ||
| > = 30 | 284 | 151(53.2%) | 85(29.9%) | 48(16.9%) | ||
| HLP (frequency, percentile) | Yes | 185 | 80(43.2%) | 54(29.2%) | 51(27.6%) | 0.185 |
| No | 682 | 314(46.0%) | 223(32.7%) | 145(21.3%) | ||
HTN Hypertension, DM Diabetes mellitus, CABG Coronary artery bypass graft, PCI Percutaneous coronary intervention, ACS Acute coronary syndrome, HF Heart failure, FH Family history, HRT Hormone replacement therapy, MI Myocardial infarction, STEMI ST-elevation myocardial infarction, NSTEMI Non ST-elevation myocardial infarction, WC Waist circumference, W/HR Waist to hip ratio, W/HtR Waist to height ratio, BMI Body mass index, HLP Hyperlipidemia, CAD Coronary artery disease